USRE33477E - Ultraviolet absorbing hydrophilic corneal contact lenses - Google Patents
Ultraviolet absorbing hydrophilic corneal contact lenses Download PDFInfo
- Publication number
- USRE33477E USRE33477E US07/369,241 US36924189A USRE33477E US RE33477 E USRE33477 E US RE33477E US 36924189 A US36924189 A US 36924189A US RE33477 E USRE33477 E US RE33477E
- Authority
- US
- United States
- Prior art keywords
- lens
- extraction
- lenses
- steady state
- corneal contact
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000605 extraction Methods 0.000 claims abstract description 33
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims abstract description 22
- 239000012736 aqueous medium Substances 0.000 claims abstract description 7
- 239000006096 absorbing agent Substances 0.000 claims description 28
- 229920000642 polymer Polymers 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000178 monomer Substances 0.000 claims description 12
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 4
- IMNBHNRXUAJVQE-UHFFFAOYSA-N (4-benzoyl-3-hydroxyphenyl) 2-methylprop-2-enoate Chemical compound OC1=CC(OC(=O)C(=C)C)=CC=C1C(=O)C1=CC=CC=C1 IMNBHNRXUAJVQE-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000000695 crystalline len Anatomy 0.000 description 99
- 238000010521 absorption reaction Methods 0.000 description 15
- 230000005540 biological transmission Effects 0.000 description 15
- 230000009102 absorption Effects 0.000 description 13
- 239000000975 dye Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 230000004438 eyesight Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 210000001525 retina Anatomy 0.000 description 6
- 238000007514 turning Methods 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 4
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 4
- 239000012965 benzophenone Substances 0.000 description 4
- 230000004456 color vision Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000004304 visual acuity Effects 0.000 description 4
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 3
- 206010002945 Aphakia Diseases 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000011358 absorbing material Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000002685 polymerization catalyst Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KKMCJEPDHKUQRC-UHFFFAOYSA-N (2-benzoylphenyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 KKMCJEPDHKUQRC-UHFFFAOYSA-N 0.000 description 1
- XRCGPZWJUXJKJF-UHFFFAOYSA-N (2-hydroxy-4-octoxyphenyl)-(2-hydroxyphenyl)methanone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1O XRCGPZWJUXJKJF-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- -1 aromatic chemical compounds Chemical class 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000882 contact lens solution Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011953 free-radical catalyst Substances 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 229920001480 hydrophilic copolymer Polymers 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- BWJUFXUULUEGMA-UHFFFAOYSA-N propan-2-yl propan-2-yloxycarbonyloxy carbonate Chemical compound CC(C)OC(=O)OOC(=O)OC(C)C BWJUFXUULUEGMA-UHFFFAOYSA-N 0.000 description 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- GJBRNHKUVLOCEB-UHFFFAOYSA-N tert-butyl benzenecarboperoxoate Chemical compound CC(C)(C)OOC(=O)C1=CC=CC=C1 GJBRNHKUVLOCEB-UHFFFAOYSA-N 0.000 description 1
- 238000000411 transmission spectrum Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
Definitions
- Such corrective lenses may be in the form of spectacles or contact lenses, but contact lenses are preferred since spectacles are not only cosmetically undesirable because of their thickness to provide the correct vision, but in addition produce an excessively large image on the retina. Even with the most suitable lenses, including contact lenses, presently in use, vision is not as desirable as it should be for the aphakic individual since such lenses do not adequately compensate for certain changes in light transmission which occur in the absence of the natural human crystalline lens. The result is a lack of visual acuity and high chromatic aberration in aphakic individuals.
- incident light is, of course, comprised of the entire spectrum of wavelengths including the ultraviolet, visible and infrared.
- the cornea preferentially absorbs that portion of the light with wavelengths up to about 340 mmu.
- the crystalline lens preferentially absorbs the wavelengths from about 340 up to about 400 mmu.
- the overall result of the various absorptions in the human eye is to permit the unabsorbed light to be transmitted to the retina, this light being defined by wavelength and intensity at each wavelength. It is apparent that in the aphakic eye, where there is no crystalline lens, light from 340 to 400 mmu will be transmitted to the retina and that absorption in the visible range of the spectrum will also be changed to the extent that such visible light was absorbed by the crystalline lens. In other words, the spectrum of the light striking the retina in the aphakic eye is different from that in the normal eye.
- Suitable lenses have now been found which restore the normal elements of vision for aphakic individuals.
- the present invention comprises an ultraviolet absorbing lens comprising a polymeric shaped body having an ultraviolet absorber dispersed substantially uniformly throughout said body, said absorber being selected from an ultraviolet absorber capable of absorbing radiation in the wavelength range of about 340 to 450 mmu (i.e., 3400 to 4500 A) and an ultraviolet absorber present in an amount such that it is capable of absorbing radiation in the wavelength of about 340 to 450 mmu, and said absorber having reached a steady state as defined herein with respect to extraction thereof from said body by an aqueous medium and to the method of making such lens.
- a preferred embodiment is directed to corneal contact lenses in which the ultraviolet absorber is a polymerizable material copolymerized with the monomeric material used to form the lens.
- the essential requirements of the present invention are that the ultraviolet absorbing polymer, from which the lens is fabricated, provides the required light absorption spectrum and that the absorbing component not be extracted in amounts which might adversely affect the eye.
- the absorbing components are aromatic chemical compounds which may be irritants to the eye or may have adverse effects if permitted to come in contact with the eye over a long period of time, such as that approaching the useful life of the lens.
- the preferred lens polymer is one that gives zero extractible of the ultraviolet absorbing component, however, polymers which give very low extractibles such as, for example, less than one part of absorbing component per million parts of lens per day are also satisfactory.
- the lens has not reached the steady state with respect to extractibles as the time that it is put into use.
- extraction will occur and the steady state reached at some time after the lens has been put into use. It is preferred but not essential to have the lens at steady state with regard to extraction prior to putting it into use, by means of an extraction procedure such as described later herein.
- the ultraviolet absorbing lenses of the present invention are, therefore, those which are capable of being brought into a steady state condition with regard to extractibles in an aqueous medium (including isotonic saline and tears) in a finite period of time.
- an extraction procedure is used prior to putting the lens in service, the extraction may be carried out in any suitable non-solvent for the polymer, such as water, saline, aliphatic hydrocarbons (such as pentene, hexane, heptane, and the like), and like extractants.
- the condition of steady state extractibility is, however, defined in terms of an aqueous medium, isotonic saline, tears, etc.
- the extraction time required to put the lens into the steady state should advantageously be as short as possible, with times of zero to seven days being preferred.
- the lens itself is a polymeric shaped body formed by polymerizing any of the monomeric materials used to make such lenses, whether the lens be of the "hard” type or the hydrophilic type ("soft" lens).
- suitable materials that can be used to form the lens are the silicone polymers and polymers comprising monomers, such as methyl methacrylate, hydroxyethyl methacrylate, ethyleneglycol dimethacrylate and mixtures thereof and the like.
- the particular monomer, or combination of monomers, as well as other additives, such as cross-linking agents and polymerization catalysts, used to form the polymeric lens form no part of the instant invention in that any known in the lens art can be used and in the proportions conventionally used for making lenses.
- the ultraviolet absorber As to the ultraviolet absorber, it must be capable of absorbing radiation in the wavelength range of about 340-450 mmu and preferably one which absorbs it above about 375 mmu and permits less than 50% and preferably less than about 30% transmission at 400 mmu. It is possible to obtain such transmission characteristics with use of known ultraviolet absorbers having the noted wavelength transmissions or by varying the concentration of known absorbers to give such absorption characteristics.
- the absorbers are preferably monomeric materials that can be copolymerized with the monomeric materials forming the shaped lens body. As described more fully later herein, this minimizes the problem of extractible materials in the lens.
- non-polymerizable absorbers are 2,2'-dihydroxy-4,4'-dimethoxy-benzophenone; 2,2'-dihydroxy-4-methoxy-benzophenone; 2,2'-dihydroxy-4-n-octyloxy-benzophenone and mixtures thereof.
- Other ultraviolet materials that can be used can be selected from the known ultraviolet absorbing materials having the capacity to absorb the wavelength transmissions necessary.
- copolymerizable monomer ultraviolet absorbers examples include ##STR1## 2-hydroxy-4-methacryloxy benzophenone and mixtures thereof.
- copolymerizable monomeric ultraviolet absorbing monomers are broadly described in U.S. Pat. No. 3,162,676 and British Pat. No. 885,986.
- a hydrophilic lens if a hydrophilic lens is to be made, then it is preferred to use a polymerizable ultraviolet absorber as this will not be leached out by virtue of the hydrophilic nature of the polymer forming the shaped body.
- the hydrophilic polymer permits absorption and elution of ingredients thereby permitting any material disposed in the lens and not part of the polymer makeup of the lens to be removed from the lens.
- visible light absorbers for selectively absorbing wavelengths in the visible region.
- Such absorbers are included in order to limit transmission of a minor percentage of visible light through the lens and onto the retina. Absent such visible light absorptions, excessive brightness can result in an aphakic individual leading to uncomfortable vision and poorer color perception.
- the usual light absorbing dyes can be used for this purpose with an orange color seemingly giving the best results.
- the maximum amount of ultraviolet absorber added to the lens is less than 5% and preferably less that 3% by weight of the monomers used to form the lens. With the polymerizable ultraviolet absorbers larger concentrations of absorber can be used since they will not be extracted from the lens.
- the amount of visible light absorber added can be that required to give the degree of light absorption desired and can vary widely, although it is desired that visible light transmission not be reduced below about 70% of the total light. Ordinarily, the amount comprises less than about 0.01 part by weight for each 100 parts by weight of the lens.
- the ultraviolet absorber and dye if such is to be added, be added to the mixture of monomers and other materials used to form the lens.
- Some initial admixing is required in order to insure the thorough dispersal of the absorbers throughout the polymerized body of the lens.
- contact lenses are formed by polymerizing the materials in a tube until the polymerization is complete. The result is a rod which is then sliced into discs and the discs converted into contact lenses by the machining procedures conventional to the contact lens art and which form no part of the instant invention.
- the extraction temperature should not exceed that at which the contact lens would be distorted.
- the extraction is preferably carried out in water or 0.9% aqueous saline at 40° C., which temperature approximates the human eye fluid temperature of about 37.5° C.
- the extraction may also be carried out in a non-aqueous medium which is a non-solvent for the polymer at the desired temperature.
- Aliphatic hydrocarbon solvents of which hexane is an example, can be used.
- the extracting solvent and temperature of extraction should be such as not to distort the part being extracted.
- the lens it is preferred to extract the lens in a state where it is as near to the final form as possible.
- One advantageous point of extraction is at the point where the entire contact lens has been fabricated except for the outside peripheral curve.
- the extracted lens can then be stored in inventory and the final curve applied when a definite prescription is received. If the lens is made to order to a known prescription, the extraction is preferably carried out after the entire lens has been fabricated.
- the attainment of a steady state is determined by analyzing aliquots of the extracting solution for its concentration of extracted ultraviolet absorber in a spectrophotometer and comparing the extent of absorption at the characteristic absorption maxima for the absorber against a calibration curve.
- a corneal contact lens was prepared from the following formulation:
- the transmission spectrum of the lenses was determined on a UV spectrophotometer. Extraction of the lenses was usually carried out by placing six lenses in a screw cap vial containing 6 mls of extracting medium and placing the vial in the desired temperature environment. To accentuate extractibility, tests were also conducted on lathe turnings of the polymer resulting from machining of the polymer rods. In these experiments usually 0.5 gram of turnings was added to the screw cap vial containing 10 ml. of extracting fluid and the results were calculated in terms of the extractible UV absorber from 0.045 grams of turnings. The extracting medium was analyzed for its concentration of extracted ultraviolet absorber by placing a 1 cc. aliquot in the spectrophotometer and comparing the extent of absorption of the characteristic absorption maxima for the absorber against a calibration curve. The wavelength, steady state, and extraction results are set forth in Table I.
- Example 13 A series of corneal contact lenses was prepared and tested as set forth in Example 1, except that different ultraviolet absorbers and/or proportions thereof were used in place of the absorber used in Example 1. In addition, in Example 13, no visible light absorbing dyes were used and, in Example 14, D&C Green #6 was substituted for the dyes used in Example 1.
- ultraviolet absorbers than shown in the above examples may be used provided they give cut-offs in the range of about 340-450 mmu with the preferred cut-off being above about 375 mmu and the transmission at 400 mmu should be in the range of less than about 50%, with the preferred range being less than about 30%. These cut-off and transmission characteristics simulate that of the human lens, whose characteristics are shown in Table I. The cut-off and transmission characteristics of a particular ultraviolet absorber can be varied to some extent by varying its concentration as can be seen by comparing Examples 1 and 2 and Examples 5 and 6.
- the methyl methacrylate monomer in the above examples may be partially replaced with comonomers to provide special physical attributes, e.g., ethylene glycol dimethacrylate as a cross-linking comonomer tends to produce a harder and more stable plastic.
- the exact nature of this monomer is not a part of this invention but generally the methacrylates are preferred for contact lens manufacture because of their optical qualities.
- the polymerization catalyst bisazoisobutyronitrile may be replaced with any suitable free radical catalyst or combinations thereof such as benzoyl peroxide, isopropyl peroxy dicarbonate, t-butyl perbenzoate, etc. These catalyst are also not a part of the subject invention.
- the dyes in Examples 1 to 11 have been chosen to provide a transmission curve in the visible region of the spectrum which simulates that of the human lens.
- concentration of the dyes may be varied depending on the desired percent of light transmission, but usually this transmission should be 70% or more for good vision.
- the chemical structure of these dyes may be different than those demonstrated here provided they perform the same purpose.
- the use of dyes is preferred but is not essential. To illustrate this point, an aphakic patient was fitted with the lens made from a polymer such as in Example 2 with visible light-screening dyes and another lens made from polymer as in Example 13 with no visible light-screening dyes and a lens made from ordinary clear polymethyl methacrylate.
- the visual acuity, comfort and color perception of the patient in bright daylight was best with the lens from Example 2.
- glare was reduced and visual acuity was better than the ordinary lens without ultraviolet absorber, but not as good as with the lens of Example 2.
- the lens made from ordinary polymethyl methacrylate did not provide any improvement in visual acuity or comfort or improvement in color perception.
- the presence of ultraviolet absorber is essential to restore natural vision, especially color vision to the aphakic patient and in combination with a visible dye provides further improvements in these qualities.
- Example 11 The methyl methacrylate monomer of Example 11 is replaced with an equal weight of hydroxyethyl methacrylate, and without any other changes polymer and contact lenses prepared. This produces a hydrophilic copolymer comprising the ultraviolet absorber in the polymer chains.
- the ultraviolet absorption at 400 mmu is 15%, the cut-off wavelength is 385 mmu and the extractible characteristics are very similar to those from Example 11.
- the ultraviolet absorber would be substantially removed by leaching. However, by interpolymerizing the ultraviolet absorber, the ultraviolet absorber is not leached out to any substantial extent.
- hydroxyethyl methacrylate may be partially or wholly replaced with other monomers while still retaining a hydrophilic ultraviolet absorbing material on polymerization.
- the other ingredients may be varied as with the non-hydrophilic examples without departing from the scope of this invention.
- Example 11 Lenses are prepared as in Example 11 except that the dyes are omitted.
- the test results will be essentially identical to that set forth for Example 11.
- Lenses are prepared as in Example 11 except that they are extracted with aliphatic hydrocarbons which are non-aqueous and non-solvents for the polymers forming the lenses. Extraction to a steady state is obtained.
- the optimum absorption characteristics can be designed into a lens without fear that exposure to eye fluids (as in the case of contact lenses) or cleansing solutions (as in the case of spectacles) with adversely alter such absorption characteristics.
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Eyeglasses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
______________________________________
Parts by Weight
______________________________________
Methyl methacrylate 95
Ethyleneglycol dimethacrylate
5
Bisazoisobutyronitrile
0.2
2,2'-dihydroxy-4,4'-dimethoxy-
0.1
benzophenone (UV absorber)
D&C Red #17 0.002
D&C Yellow #11 0.004
______________________________________
TABLE I
__________________________________________________________________________
Micrograms Extracted at Start
of
Concen- Steady State and (Steady
State
tration Cut-off
% Trans-
Days to Extraction Rate.sup.4 of UV
Absorber)
Parts/100 Wave-
mission.sup.2
Steady State mcgm per ml. per
Example Parts Polymeri-
length.sup.1
at 400
Extraction at
mcgm per .045 gms turnings/
No. UV Absorber
Monomer
zable (mmu)
(mmu)
Ambient Temp..sup.3
lens per day
day
__________________________________________________________________________
1 2,2'-dihydroxy-
0.1 No 370 30 17-20 0.045 0.117
4,4' dimethoxy- (0.00016)
(0.0014)
benzophenone
2 2,2'-dihydroxy-
0.5 No 385 10 20 0.160 0.630
4,4' dimethoxy (0.00070)
(0.0051)
benzophenone
3 2,2'-dihydroxy-
0.1 No 360 43 16 N.A. Extracted 0.09
4-methoxy- at 16 days,
benzophenone 40° C.
4 2,2'-dihydroxy-
0.1 No 360 41 16 N.A. N.A.
4-η-octyloxy-
benzophenone
5 Compound I
1.0 Yes 360 44 Extracted 4
N.A. 0.57
days at 70° C.
see footnote.sup.5
and 3 days at
Room Temp..sup.5
6 Compound I
3.0 Yes 365 36 Extracted 4
N.A. 0.52
days at 70° C.
see footnote.sup.5
and 3 days at
Room Temp..sup.5
7 2,2'-dihydroxy-
0.5 No 385 10 Extracted 1 day
0.304 0.99
4,4'-dimethoxy at 70° C. and
see footnote.sup.5
see footnote.sup.5
benzophenone days at R.T.
8 Compound II
0.55 Yes 380 26 4 (40° C.)
N.A. 0.0180
(0.0019-40°
C.)
9 Compound II
0.40 Yes 375 28 3-4 (40° C.)
N.A. 0.0288
(0.0017-40°
C.)
10 Compound II
0.8 Yes 380 17 4 (40° C.)
N.A. 0.0279
(0.00040-40° C.)
(0.00162-40°
C.)
11 Compound II
1.0 Yes 390 13
Human -- -- -- 388 5 -- -- --
Lens
12 2-hydroxy-4-
0.6 Yes 340 46 N.A. N.A. N.A.
methacryloxy
benzophenone
13 2,2'-dihydroxy-
0.5 No 390 22 17-20 0.20 0.53
4,4' dimethoxy- (0.0008) (0.0075)
14 2,2'-dihydroxy-
0.5 No 390 22 17-20 0.20 0.50
4,4' dimethoxy- (0.008) (0.0072)
benzophenone
__________________________________________________________________________
.sup.1 Determined on a 0.020 inch thick lens. CutOff Wavelength is that a
which the transmission reached 0%.
.sup.2 Extractant is a 0.9% aqueous saline solution. Extraction at room
temperature.
.sup.3 Temperatures other than room temperature are noted in parentheses.
Steady state means that the rate of extraction is constant.
.sup.4 Tests were preformed on groups of 6 lenses with 6 ml. of extractin
medium or on 0.5 gram of lathe turnings with 10 ml. of extracting medium
or both.
.sup.5 Days to steady state not available; numbers shown are at the end o
the indicated treatment.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/369,241 USRE33477E (en) | 1973-06-20 | 1989-06-20 | Ultraviolet absorbing hydrophilic corneal contact lenses |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37160373A | 1973-06-20 | 1973-06-20 | |
| US07/369,241 USRE33477E (en) | 1973-06-20 | 1989-06-20 | Ultraviolet absorbing hydrophilic corneal contact lenses |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US37160373A Division | 1973-06-20 | 1973-06-20 | |
| US05/741,695 Reissue US4304895A (en) | 1973-06-20 | 1976-11-15 | Ultraviolet absorbing corneal contact lenses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USRE33477E true USRE33477E (en) | 1990-12-04 |
Family
ID=27004507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/369,241 Expired - Lifetime USRE33477E (en) | 1973-06-20 | 1989-06-20 | Ultraviolet absorbing hydrophilic corneal contact lenses |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USRE33477E (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164462A (en) * | 1991-04-25 | 1992-11-17 | Allergan, Inc. | Ultraviolet light absorbing compounds and silicone compositions |
| US5258490A (en) * | 1987-12-14 | 1993-11-02 | Chang Sing Hsiung | Non-irritating soft gas permeable contact lens and process for producing same |
| US5376737A (en) * | 1991-04-25 | 1994-12-27 | Allergan, Inc. | Methods for benefitting polymers |
| US5637726A (en) * | 1993-04-22 | 1997-06-10 | Wesley-Jessen Corporation | UV-absorbing benzotriazoles having a styrene group |
| EP0782031A1 (en) * | 1995-12-29 | 1997-07-02 | ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) | Multifocal artificial ocular lens with variable light transmission depending on luminous intensity |
| US5681871A (en) * | 1995-05-24 | 1997-10-28 | Johnson & Johnson Vision Products, Inc. | Method for preparing ultraviolet radiation absorbing contact lenses |
| US6244707B1 (en) | 1998-07-21 | 2001-06-12 | Wesley Jessen Corporation | UV blocking lenses and material containing benzotriazoles and benzophenones |
| US6432137B1 (en) | 1999-09-08 | 2002-08-13 | Medennium, Inc. | High refractive index silicone for use in intraocular lenses |
| US6649722B2 (en) | 1999-12-10 | 2003-11-18 | Novartis Ag | Contact lens |
| US6815074B2 (en) | 2001-05-30 | 2004-11-09 | Novartis Ag | Polymeric materials for making contact lenses |
| US20050070661A1 (en) * | 2003-09-30 | 2005-03-31 | Frank Molock | Methods of preparing ophthalmic devices |
| US20060197067A1 (en) * | 2005-03-04 | 2006-09-07 | Erning Xia | Radiation-absorbing materials, ophthalmic compositions containing same, and method of treating ophthalmic devices |
| US20080137030A1 (en) * | 2006-11-03 | 2008-06-12 | Hoffman William C | Optical devices with reduced chromatic aberration |
| US9005700B2 (en) | 2011-10-12 | 2015-04-14 | Novartis Ag | Method for making UV-absorbing ophthalmic lenses |
| US9052439B2 (en) | 2010-07-30 | 2015-06-09 | Novartis Ag | Method for making UV-absorbing ophthalmic lenses |
| US9594188B2 (en) | 2011-12-06 | 2017-03-14 | University Of Florida Research Foundation, Inc. | UV blocker loaded contact lenses |
| US10338408B2 (en) | 2012-12-17 | 2019-07-02 | Novartis Ag | Method for making improved UV-absorbing ophthalmic lenses |
| CN112731685A (en) * | 2021-01-29 | 2021-04-30 | 甘肃天后光学科技有限公司 | Photochromic soft corneal contact lens and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3171869A (en) * | 1959-12-07 | 1965-03-02 | Bausch & Lomb | Process for manufacturing curved optical articles |
| US3173893A (en) * | 1962-06-18 | 1965-03-16 | Nat Starch Chem Corp | Polymeric compositions resistant to ultra-violet light containing benzophenone derivatives |
| US4304895A (en) * | 1973-06-20 | 1981-12-08 | Wesley-Jessen, Inc. | Ultraviolet absorbing corneal contact lenses |
| US4390676A (en) * | 1976-11-15 | 1983-06-28 | Schering Corporation | Ultraviolet absorbing lenses |
-
1989
- 1989-06-20 US US07/369,241 patent/USRE33477E/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3171869A (en) * | 1959-12-07 | 1965-03-02 | Bausch & Lomb | Process for manufacturing curved optical articles |
| US3173893A (en) * | 1962-06-18 | 1965-03-16 | Nat Starch Chem Corp | Polymeric compositions resistant to ultra-violet light containing benzophenone derivatives |
| US4304895A (en) * | 1973-06-20 | 1981-12-08 | Wesley-Jessen, Inc. | Ultraviolet absorbing corneal contact lenses |
| US4390676A (en) * | 1976-11-15 | 1983-06-28 | Schering Corporation | Ultraviolet absorbing lenses |
Non-Patent Citations (3)
| Title |
|---|
| Fertig Article (Journal of Applied Polymer Science), vol. 10, pp. 663 672. * |
| Fertig Article (Journal of Applied Polymer Science), vol. 10, pp. 663-672. |
| UVC Brochure (Guaranteed Plastic Lenses), undated document. * |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258490A (en) * | 1987-12-14 | 1993-11-02 | Chang Sing Hsiung | Non-irritating soft gas permeable contact lens and process for producing same |
| US5164462A (en) * | 1991-04-25 | 1992-11-17 | Allergan, Inc. | Ultraviolet light absorbing compounds and silicone compositions |
| US5376737A (en) * | 1991-04-25 | 1994-12-27 | Allergan, Inc. | Methods for benefitting polymers |
| US5637726A (en) * | 1993-04-22 | 1997-06-10 | Wesley-Jessen Corporation | UV-absorbing benzotriazoles having a styrene group |
| US5866635A (en) * | 1993-04-22 | 1999-02-02 | Wesley Jessen Corporation | UV-absorbing benzotriazoles having a styrene group |
| US5681871A (en) * | 1995-05-24 | 1997-10-28 | Johnson & Johnson Vision Products, Inc. | Method for preparing ultraviolet radiation absorbing contact lenses |
| EP0782031A1 (en) * | 1995-12-29 | 1997-07-02 | ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) | Multifocal artificial ocular lens with variable light transmission depending on luminous intensity |
| FR2743154A1 (en) * | 1995-12-29 | 1997-07-04 | Essilor Int | MULTIFOCAL ARTIFICIAL OCULAR LENS WITH VARIABLE TRANSPARENCY WITH LIGHTING |
| US6017121A (en) | 1995-12-29 | 2000-01-25 | Essilor International Compagnie Generale D'optique | Multifocal artificial ocular lens with a transparency varying with illumination |
| US6224210B1 (en) | 1995-12-29 | 2001-05-01 | Essilor International Compagnie Generale D'optique | Multifocal artificial ocular lens with a transparency varying with illumination |
| US6244707B1 (en) | 1998-07-21 | 2001-06-12 | Wesley Jessen Corporation | UV blocking lenses and material containing benzotriazoles and benzophenones |
| US6432137B1 (en) | 1999-09-08 | 2002-08-13 | Medennium, Inc. | High refractive index silicone for use in intraocular lenses |
| US6649722B2 (en) | 1999-12-10 | 2003-11-18 | Novartis Ag | Contact lens |
| US20060012751A1 (en) * | 1999-12-10 | 2006-01-19 | Rosenzweig Howard S | Contact lens |
| US7201481B2 (en) | 1999-12-10 | 2007-04-10 | Novartis Ag | Contact lens |
| US6815074B2 (en) | 2001-05-30 | 2004-11-09 | Novartis Ag | Polymeric materials for making contact lenses |
| US20050070661A1 (en) * | 2003-09-30 | 2005-03-31 | Frank Molock | Methods of preparing ophthalmic devices |
| US20060197067A1 (en) * | 2005-03-04 | 2006-09-07 | Erning Xia | Radiation-absorbing materials, ophthalmic compositions containing same, and method of treating ophthalmic devices |
| US20080137030A1 (en) * | 2006-11-03 | 2008-06-12 | Hoffman William C | Optical devices with reduced chromatic aberration |
| US9052439B2 (en) | 2010-07-30 | 2015-06-09 | Novartis Ag | Method for making UV-absorbing ophthalmic lenses |
| US9005700B2 (en) | 2011-10-12 | 2015-04-14 | Novartis Ag | Method for making UV-absorbing ophthalmic lenses |
| US9594188B2 (en) | 2011-12-06 | 2017-03-14 | University Of Florida Research Foundation, Inc. | UV blocker loaded contact lenses |
| US9885886B2 (en) | 2011-12-06 | 2018-02-06 | University Of Florida Research Foundation, Inc. | UV blocker loaded contact lenses |
| US10338408B2 (en) | 2012-12-17 | 2019-07-02 | Novartis Ag | Method for making improved UV-absorbing ophthalmic lenses |
| CN112731685A (en) * | 2021-01-29 | 2021-04-30 | 甘肃天后光学科技有限公司 | Photochromic soft corneal contact lens and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4304895A (en) | Ultraviolet absorbing corneal contact lenses | |
| US4390676A (en) | Ultraviolet absorbing lenses | |
| USRE33477E (en) | Ultraviolet absorbing hydrophilic corneal contact lenses | |
| AU757384B2 (en) | UV blocking lenses and material containing benzotriazoles and benzophenones | |
| US5846457A (en) | Light filtering contact lens method | |
| US5617154A (en) | Light filtering contact lens | |
| US8133274B2 (en) | Photochromic intraocular lenses and methods of making the same | |
| EP2875091B1 (en) | Light absorbing compounds for optical polymers | |
| US6224945B1 (en) | Process for the manufacture of a crosslinked, transparent, hydrophilic and photochromic polymeric material, and optical and ophthalmic articles obtained | |
| WO2008057990A2 (en) | Optical devices with reduced chromatic aberration | |
| KR102259281B1 (en) | Contact lenses for blocking blue light and methods of manufacturing the same | |
| JPH11255925A (en) | Modification of medical polymer and polymer base material for medical purpose | |
| JP2011500898A (en) | Hydrogel with high moisture content and stability | |
| JPH0824694B2 (en) | Contact lenses for correcting blue eyes | |
| WO1989007952A1 (en) | Process for producing intraocular lens for correcting cyanopia | |
| US20210011200A1 (en) | Functional contact lens and method for dyeing the same | |
| JPH0724052A (en) | Soft eye-inlying lens for correcting protanopia | |
| KR102199118B1 (en) | Blue light blocking composition and the blue light blocking contact lens using the same and the manufacturing method thereof | |
| CN107641168B (en) | Polymer, preparation method and application thereof | |
| KR101123643B1 (en) | Contact lens comprising ultraviolet rays absorption material and preparation method thereof | |
| KR20190020962A (en) | Soft contact lends | |
| KR102279488B1 (en) | Blue light blocking contact lens using Tatrazine pigment and its manufacturing method | |
| US4280759A (en) | Permeable wettable contact lens | |
| JP3104417B2 (en) | Optical materials | |
| JP2724012B2 (en) | Manufacturing method of intraocular lens for blue vision correction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: SCHERING CORPORATION, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WESLEY-JESSEN CORPORATION;REEL/FRAME:007521/0875 Effective date: 19950627 |
|
| AS | Assignment |
Owner name: WJ ACQUISITION CORP., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SCHERING CORPORATION AND ITS WHOLLY-OWNED SUBIDIARY WESLEY-JESSEN CORPORATION;REEL/FRAME:007558/0256 Effective date: 19950628 |
|
| AS | Assignment |
Owner name: WESLEY-JESSEN CORPORATION, ILLINOIS Free format text: CHANGE OF NAME;ASSIGNOR:WU-ACQUISITION CORP.;REEL/FRAME:007596/0466 Effective date: 19950630 |
|
| AS | Assignment |
Owner name: BANKERS TRUST COMPANY, NEW YORK Free format text: GRANT OF SECURITY INTEREST;ASSIGNOR:WESLEY-JESSEN CORPORATION;REEL/FRAME:008251/0182 Effective date: 19961002 |
|
| AS | Assignment |
Owner name: WESLEY-JESSEN CORPORATION, ILLINOIS Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANKERS TRUST COMPANY;REEL/FRAME:011821/0589 Effective date: 20010427 |
|
| AS | Assignment |
Owner name: WESLEY-JESSEN CORPORATION, ILLINOIS Free format text: RELEASE OF A SECURITY INTEREST;ASSIGNOR:BANKERS TRUST COMPANY;REEL/FRAME:011821/0594 Effective date: 20010427 |
|
| AS | Assignment |
Owner name: NOVARTIS AG, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WESLEY JESSEN CORPORATION;REEL/FRAME:013852/0622 Effective date: 20021218 |